Prognostic Value of Right Ventricular Dysfunction in Patients With Decompensated Chronic Heart Failure
https://doi.org/10.18087/cardio.2023.3.n2071
Abstract
Aim To determine the incidence rate and the practical significance of right ventricular dysfunction (RVD) in the development of cardiovascular complications in patients with decompensated chronic heart failure (DCHF).
Material and methods This prospective, single-site observational study included 171 patients older than 18 years with NYHA functional class (FC) II-IV chronic heart failure (CHF) who were hospitalized for DCHF. Standard and extended 2D and 3D echocardiography (EchoCG) was performed for all patients on admission. Additionally, functional characteristics of the right ventricle (RV) were evaluated in the 3D mode followed by autonomic 3D processing with a EchoPac station (USA). RVD was taken as a disorder of two or more RV functional parameters according to results of 2D EchoCG, or a reduced RV free wall strain according to results of 2D speckle-tracking EchoCG, or a reduced RV ejection fraction (EF) according to results of 3D EchoCG. Statistical analysis was performed with a SPSS Statistics v. 26.0 software.
Results The incidence rate of RVD in general population of patients with DCHF was 75.4 % (n=129). A higher prevalence of RVD was observed in patients with CHF with a low left ventricular (LV) EF (90.1 %). Patients with RVD had a more severe clinical status (significantly higher FC and higher Clinical Condition Scale (CCS) scores), more frequent atrial fibrillation (AF), and higher concentrations of uric acid and total bilirubin. RVD significantly correlated with male sex (odds ratio (OR), 2.05; 95 % confidence interval (CI), 1.01–4.19; р=0.046) and AF (OR, 3.52; 95 % CI, 1.71–7.26; р<0.001). Patients with RVD had lower values of both LV and RV function. Lower LV EF and AF increased the probability of RVD by 1.06 times (95 % CI, 0.90–0.98; р=0.001) and by 2.63 times (95 % CI, 1.08–6.40; р=0.001), respectively. Evaluation of the predictive significance of RV parameters measured by 2D and 3D EchoCG showed only effects of RV EF (2D) and RV global longitudinal strain (GLS) (3D) on all-cause hospitalization. RVD as evaluated by accepted criteria did not influence adverse outcomes.
Conclusion The determined incidence, correlations, and the predictive value of RVD in patients with DCHF indicated the appropriateness of assessing the RV function to optimize the management of patients regardless of the CHF phenotype.
About the Authors
M. R. IslamovaRussian Federation
PhD student, Department of Internal Medicine with Course of Cardiology and Functional Diagnostics
Competing Interests:
A. F. Safarova
Russian Federation
MD, PhD, Professor, Department of Internal Medicine with Course of Cardiology and Functional Diagnostics
Zh. D. Kobalava
Russian Federation
MD, PhD, Professor, Corresponding member of the Russian Academy of Sciences, Head of the Department of Internal Medicine with Course of Cardiology and Functional Diagnostics
V. P. Efimova
Russian Federation
MD,PhD, Head of the Department of Ultrasound and Functional Diagnostic Methods
References
1. Motiejunaite J, Celutkiene J, Mebazaa A. The right ventricle drives the progression of heart failure: The right ventricle drives the progression of heart failure. European Journal of Heart Failure. 2017;19(12):1737–1737. DOI: 10.1002/ejhf.981
2. Harjola V-P, Mebazaa A, Čelutkienė J, Bettex D, Bueno H, Chioncel O et al. Contemporary management of acute right ventricular failure: a statement from the Heart Failure Association and the Working Group on Pulmonary Circulation and Right Ventricular Function of the European Society of Cardiology. European Journal of Heart Failure. 2016;18(3):226–41. DOI: 10.1002/ejhf.478
3. Santiago-Vacas E, Lupón J, Gavidia-Bovadilla G, Gual-Capllonch F, Antonio M, Domingo M et al. Pulmonary hypertension and right ventricular dysfunction in heart failure: prognosis and 15-year prospective longitudinal trajectories in survivors. European Journal of Heart Failure. 2020;22(7):1214–25. DOI: 10.1002/ejhf.1862
4. Dutta T, Aronow WS. Echocardiographic evaluation of the right ventricle: Clinical implications. Clinical Cardiology. 2017;40(8):542–8. DOI: 10.1002/clc.22694
5. Sergeyeva L.I., Kozhura V.L., Churlyaev Yu.A. Development of Right Ventricular Dysfunction in Acute Myocardial Infarction and Chronic Heart Failure. General Reanimatology. 2007;3(2):57–60.
6. Poteshkina N.G., Demkina A.E., Krylova N.S., Kovalevskaya E.A., Khashieva F.M. Impact of the right ventricle dysfunction on chronic heart failure presentation in patients with hypertrophic cardiomyopathy. Russian Journal of Cardiology. 2016;21(8):53–7. DOI: 10.15829/1560-4071-2016-8-53-57
7. Islamova M.R., Lazarev P.V., Safarova A.F., Kobalava Zh.D. The Value of Right Ventricular Dysfunction and Right Ventricular-Pulmonary Artery Coupling in Chronic Heart Failure: The Role of Echocardiography. Kardiologiia. 2018;58(5):82–90. DOI: 10.18087/cardio.2018.5.10124
8. Raina A, Meeran T. Right Ventricular Dysfunction and Its Contribution to Morbidity and Mortality in Left Ventricular Heart Failure. Current Heart Failure Reports. 2018;15(2):94–105. DOI: 10.1007/s11897-018-0378-8
9. Muraru D, Spadotto V, Cecchetto A, Romeo G, Aruta P, Ermacora D et al. New speckle-tracking algorithm for right ventricular volume analysis from three-dimensional echocardiographic data sets: validation with cardiac magnetic resonance and comparison with the previous analysis tool. European Heart Journal – Cardiovascular Imaging. 2016;17(11):1279–89. DOI: 10.1093/ehjci/jev309
10. Zhang QB, Sun JP, Gao RF, Lee AP-W, Feng YL, Liu XR et al. Feasibility of single-beat full-volume capture real-time three-dimensional echocardiography for quantification of right ventricular volume: Validation by cardiac magnetic resonance imaging. International Journal of Cardiology. 2013;168(4):3991–5. DOI: 10.1016/j.ijcard.2013.06.088
11. Pickett CA, Cheezum MK, Kassop D, Villines TC, Hulten EA. Accuracy of cardiac CT, radionucleotide and invasive ventriculography, two- and three-dimensional echocardiography, and SPECT for left and right ventricular ejection fraction compared with cardiac MRI: a meta-analysis. European Heart Journal – Cardiovascular Imaging. 2015;16(8):848–52. DOI: 10.1093/ehjci/jeu313
12. Surkova E.A., Kovács A. Comprehensive Echocardiographic Assessment of the Right Ventricular Performance: beyond TAPSE and Fractional Area Change. Russian Journal of Cardiology. 2020;25(S3):24–34. DOI: 10.15829/1560-4071-2020-4067
13. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K et al. Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography. Journal of the American Society of Echocardiography. 2010;23(7):685–713. DOI: 10.1016/j.echo.2010.05.010
14. Gorter TM, van Veldhuisen DJ, Bauersachs J, Borlaug BA, Celutkiene J, Coats AJS et al. Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology. European Journal of Heart Failure. 2018;20(1):16–37. DOI: 10.1002/ejhf.1029
15. Vachiéry J-L, Adir Y, Barberà JA, Champion H, Coghlan JG, Cottin V et al. Pulmonary Hypertension Due to Left Heart Diseases. Journal of the American College of Cardiology. 2013;62(25 Suppl):D100–8. DOI: 10.1016/j.jacc.2013.10.033
16. Ghio S, Guazzi M, Scardovi AB, Klersy C, Clemenza F, Carluccio E et al. Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction: RV function in heart failure. European Journal of Heart Failure. 2017;19(7):873–9. DOI: 10.1002/ejhf.664
17. Bosch L, Lam CSP, Gong L, Chan SP, Sim D, Yeo D et al. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction. European Journal of Heart Failure. 2017;19(12):1664–71. DOI: 10.1002/ejhf.873
18. Kanagala P, Arnold JR, Singh A, Khan JN, Gulsin GS, Gupta P et al. Prevalence of right ventricular dysfunction and prognostic significance in heart failure with preserved ejection fraction. The International Journal of Cardiovascular Imaging. 2021;37(1):255–66. DOI: 10.1007/s10554-020-01953-y
19. Melenovsky V, Hwang S-J, Lin G, Redfield MM, Borlaug BA. Right heart dysfunction in heart failure with preserved ejection fraction. European Heart Journal. 2014;35(48):3452–62. DOI: 10.1093/eurheartj/ehu193
20. Guendouz S, Rappeneau S, Nahum J, Dubois-Randé J-L, Gueret P, Monin J-L et al. Prognostic significance and normal values of 2D strain to assess right ventricular systolic function in chronic heart failure. Circulation Journal: Official Journal of the Japanese Circulation Society. 2012;76(1):127–36. PMID: 22033348
21. Cenkerova K, Dubrava J, Pokorna V, Kaluzay J, Jurkovicova O. Right ventricular systolic dysfunction and its prognostic value in heart failure with preserved ejection fraction. Acta Cardiologica. 2015;70(4):387–93. DOI: 10.1080/ac.70.4.3094646
Review
For citations:
Islamova M.R., Safarova A.F., Kobalava Zh.D., Efimova V.P. Prognostic Value of Right Ventricular Dysfunction in Patients With Decompensated Chronic Heart Failure. Kardiologiia. 2023;63(3):13-20. https://doi.org/10.18087/cardio.2023.3.n2071